How has been the historical performance of 3B Blackbio?

Answer:The historical performance of 3B Blackbio shows significant fluctuations in key financial metrics over the years.

Breakdown:
3B Blackbio's net sales have shown a general upward trend from Mar'20 to Mar'25, increasing from 28.87 Cr in Mar'20 to 96.47 Cr in Mar'25, despite a dip in Mar'22. The total operating income followed a similar pattern, reaching 96.47 Cr in Mar'25. The raw material costs have also risen, peaking at 50.76 Cr in Mar'21 before decreasing to 26.01 Cr in Mar'25. Operating profit (PBDIT) saw a high of 152.88 Cr in Mar'21 but has since decreased to 65.19 Cr in Mar'25. Profit before tax has increased steadily from 6.95 Cr in Mar'19 to 64.00 Cr in Mar'25, while profit after tax has also risen from 5.24 Cr in Mar'19 to 47.69 Cr in Mar'25. The company's earnings per share (EPS) peaked at 132.88 in Mar'21 but has since stabilized at 55.6 in Mar'25. On the balance sheet, total assets grew from 36.34 Cr in Mar'19 to 248.10 Cr in Mar'24, with total liabilities also increasing but at a slower rate. Cash flow from operating activities has shown a positive trend, reaching 26.00 Cr in Mar'24, while net cash inflow was 2.00 Cr in the same period. Overall, 3B Blackbio has demonstrated resilience and growth in its financial performance, despite some volatility in specific areas.